📊 What’s Driving The Market

Warsh turned hawkish at Jackson Hole: Stocks slipped as the Fed chair’s first keynote read mildly hawkish, with the S&P down 0.3% and the Nasdaq off 0.5% after early gains, while the Dow held roughly flat. The reaction reversed an intraday advance as traders digested the tone.
Inflation framing spooked rate bets: Warsh said the summer’s PCE and CPI readings were better than expected but did not show that underlying trends had meaningfully improved, calling inflation too high and price stability the Fed’s predominant focus.
September hike odds spiked to 57%: Markets moved to price a better-than-even chance of a rate hike at the September meeting, a hawkish repricing from the prior hold-leaning stance that pressured rate-sensitive and higher-beta groups.
Stocks still closed the week green: Despite Friday’s dip, all three indexes posted weekly gains, with the S&P up 0.5%, the Nasdaq up 0.9%, and the Dow up 0.5% for its first winning week in three, leaving the tape resilient into month-end.

OptionsPlay Trade Ideas: The Daily Brief

💰 The Income Generators (High Probability, Cash Flow)

RMD: Selling a put spread as ResMed breaks out above $230 on relative outperformance toward $260.

🚀 The Growth Seekers (Higher Risk, Max Reward)

CME: Buying a call spread to add to our winning CME position on the breakout above $270.

🛡️ The Portfolio Protectors (Hedges & Bearish Bets)

TXN: Buying a put spread as Texas Instruments breaks down below $275 toward a $235 gap fill.

1. RMD ($240.33): Selling a Put Spread on the Breakout Above $230

We’re betting on: ResMed has broken out above $230 while outperforming the S&P 500, and for RMD to stay above $240 through expiration to keep the full credit.
The Trade: Sell to Open the RMD Oct 16, 2026 240/230 Put Vertical @ $3.85 Credit.
- 🔴 SELL TO OPEN Oct 16, 2026 240 Put @ $8.65
- 🟢 BUY TO OPEN Oct 16, 2026 230 Put @ $4.80
Trade Metrics: POP: 55.58% | Collect $385 per contract vs. a Max Risk of $615 (1.60:1).
The Setup: RMD broke out above its $230 resistance to $240.33 while outperforming the S&P 500, in a bullish 1-month and 6-month trend with a $260 target. Relative strength is still neutral at 5/10, so the short strike sits right at the money to reflect that the recovery is maturing rather than fully confirmed. ResMed is the leader in sleep-apnea and respiratory devices, a defensive med-tech franchise with steady cash flow that fits a more cautious tape following the hawkish Fed tone. The 240/230 put vertical collects $385 and risks $615, a 1.60:1 payout on strictly defined risk, with a breakeven of $236.15 and full profit if RMD holds above the $240 short strike through October expiration.
Management:
- Stop Loss: Buy back the spread at $7.70 (100% loss of the credit received).
- Take Profit: Buy back the spread at $1.93 (50% of the credit captured).

2. CME ($285.80): Adding to the Winner on the Breakout Above $270

We’re betting on: CME Group broke out above $270 on strong volume and relative strength, and for CME to close above $310 by expiration to capture the full spread.
The Trade: Buy to Open the CME Oct 16, 2026 280/310 Call Vertical @ $10.62 Debit.
- 🟢 BUY TO OPEN Oct 16, 2026 280 Call @ $13.25
- 🔴 SELL TO OPEN Oct 16, 2026 310 Call @ $2.63
Trade Metrics: POP: 41.58% | Pay $1,062 per contract vs. a Max Reward of $1,938 (1.82:1).
The Setup: CME broke out above its $270 level to $285.80 on strong volume while outperforming the S&P 500, in a bullish 1-month and 6-month trend targeting the $310 area. This adds to a winning CME position we already hold as the exchange operator benefits from the higher-volatility, higher-rate backdrop that the hawkish Fed tone reinforces, both through elevated trading volumes and richer income on customer float. Relative strength is still weak at 3/10, so this is a trend-following add before the relative-strength picture catches up. The 280/310 call vertical costs $1,062 and pays up to $1,938 if CME reaches $310, a 1.82:1 payout on strictly defined risk, with a breakeven of $290.62 and maximum value at or above the $310 short strike by October expiration.
Management:
- Stop Loss: Sell the spread at $5.31 (50% loss on premium).
- Take Profit: Sell the spread at $18.59 (75% gain on premium).

3. TXN ($258.64): Buying the Breakdown Toward a $235 Gap Fill

We’re betting on: Texas Instruments has broken down below $275 in a bearish trend, and for TXN to fall toward $230 by expiration to capture the full spread.
The Trade: Buy to Open the TXN Oct 16, 2026 260/230 Put Vertical @ $10.00 Debit.
- 🟢 BUY TO OPEN Oct 16, 2026 260 Put @ $13.78
- 🔴 SELL TO OPEN Oct 16, 2026 230 Put @ $3.78
Trade Metrics: POP: 42.47% | Pay $1,000 per contract vs. a Max Reward of $2,000 (2.00:1).
The Setup: TXN broke down below its $275 support to $258.64, in a bearish 1-month and mildly bearish 6-month trend after rolling over from a summer top, with the breakdown pointing to a potential gap fill toward $235 as an initial downside target. This is a bearish hedge that also balances the book against our bullish positions, and it fits a more cautious tape following the hawkish Fed tone, with a richly valued semiconductor at roughly 40 times earnings vulnerable to further multiple compression. The 260/230 put vertical costs $1,000 and pays up to $2,000 if TXN falls to $230, a 2.00:1 payout on strictly defined risk, with a breakeven of $250.00 and maximum value at or below the $230 short strike by October expiration.
Management:
- Stop Loss: Sell the spread at $5.00 (50% loss on premium).
- Take Profit: Sell the spread at $17.50 (75% gain on premium).